The increasing interest in successful weight management has resulted in considerable exploration into groundbreaking treatments. Lately , Retatrutide, a combined -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has demonstrated positive results in patient trials, suggesting potential for significant weight